FIRM FIXED PRICENO SET ASIDE USED.

10X GENOMICS, INC. - [26-000772] NHLBI LABORATORY OF CARDIOVASCULAR REGENERATIVE MEDICINE REQUIRES GEM-X UNIVERSAL 3 GENE EXPRESSION CDNA KIT V4 16 SAMPLES IN ORDER TO CONTINUE PATIENT RELATED EXPERIMENTS ON IN VIVO AND IN VITRO TISSUE SAMPLES

PIID: 75N92026F00001

Signed Date: Dec 11, 2025Effective Date: Dec 8, 2025End Date: Closed on Mar 8, 2026

Award $

$22K

Vendor

10X GENOMICS, INC.

NAICS

325413

Signed Date

Dec 11, 2025

Key Details

Dollars Obligated

$22,420

Base & All Options

$22,420

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

325413 - IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Product Service Code

6640 - LABORATORY EQUIPMENT AND SUPPLIES

Extent Competed

COMPETED UNDER SAP

Number of Offers

Place of Performance

PLEASANTON, CA, 945883260, CD-CA-14

Description

[26-000772] NHLBI LABORATORY OF CARDIOVASCULAR REGENERATIVE MEDICINE REQUIRES GEM-X UNIVERSAL 3 GENE EXPRESSION CDNA KIT V4 16 SAMPLES IN ORDER TO CONTINUE PATIENT RELATED EXPERIMENTS ON IN VIVO AND IN VITRO TISSUE SAMPLES

Context & Analysis

On Dec 11, 2025, Department of Health and Human Services obligated $22,420 to 10X GENOMICS, INC. for [26-000772] nhlbi laboratory of cardiovascular regenerative medicine requires gem-x universal 3 gene expression cdna kit v4 16 samples in order to continue patient related experiments on in vivo and i…. The award is classified under NAICS 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING and issued as a firm fixed price contract. Competition extent: competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in PLEASANTON, CA.